Project measures / variables set:   Xenakis2   PI15

ID, description, units MPD:118387   PI15   plasma insulin, 15 min after intraperitoneal (i.p. 0.2% glucose, 6h fast) injection   [ng/mL]  
arsenic study
Measures
• iAs:    • 1 wk before    • 13 wks after    • 25 wks after
Data set, strains Xenakis2   DO population   1 strains     sex: m     age: 7-33wks
Procedure hormone quantification
Comparisonrepeated measures, baseline then treated, same cohort
Ontology mappings

  SIDE-BY-SIDE STRAIN CURVES
Values
Graph Type
Dimensions Width:  ×  Height: px
Plot Options


  OVERLAPPING STRAIN CURVES
Data
Dimensions px
Toggle Series   
Plot Options
Advanced Plot Options
Separate Plot Factor(s)
Legend Factor(s)
X-Axis Factor(s)
Include/Exclude Factor Values

Xenakis2 - plasma insulin, 15 min after intraperitoneal (i.p. 0.2% glucose, 6h fast) injection




  INDIVIDUAL MEASURES
ProjectIDTreatmentMeasure / Variable Description PanelStrains
tested		SexAge
Xenakis2 118387 hormone quantification arsenic plasma insulin, 15 min after intraperitoneal (i.p. 0.2% glucose, 6h fast) injection   [ng/mL]   1 wk before  PI15_1wksBef DO population m 7wks
Xenakis2 118388 hormone quantification arsenic plasma insulin, 15 min after intraperitoneal (i.p. 0.2% glucose, 6h fast) injection   [ng/mL]   13 wks after  PI15_13wks DO population m 21wks
Xenakis2 118389 hormone quantification arsenic plasma insulin, 15 min after intraperitoneal (i.p. 0.2% glucose, 6h fast) injection   [ng/mL]   25 wks after  PI15_25wks DO population m 33wks



  •   Or, add these measures to your collection.
       
  •     no folder
  •     put them in new folder